Detalhe da pesquisa
1.
Phase 2 trial of tremelimumab in patients with metastatic urothelial cancer previously treated with programmed death 1/programmed death ligand 1 blockade.
Cancer
; 130(9): 1642-1649, 2024 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38180804
2.
Comprehensive genomic profiling of penile squamous cell carcinoma and the impact of human papillomavirus status on immune-checkpoint inhibitor-related biomarkers.
Cancer
; 129(24): 3884-3893, 2023 12 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37565840
3.
Baseline Neutrophil-to-Eosinophil Ratio Is Associated with Outcomes in Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors.
Oncologist
; 28(3): 239-245, 2023 03 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-36427017
4.
Immune-Related Adverse Events and Clinical Outcomes in Advanced Urothelial Cancer Patients Treated With Immune Checkpoint Inhibitors.
Oncologist
; 28(12): 1072-1078, 2023 Dec 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37285524
5.
Safety and efficacy of nivolumab plus ipilimumab in patients with advanced renal cell carcinoma with brain metastases: CheckMate 920.
Cancer
; 128(5): 966-974, 2022 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34784056
6.
18F-fluciclovine-PET/CT imaging versus conventional imaging alone to guide postprostatectomy salvage radiotherapy for prostate cancer (EMPIRE-1): a single centre, open-label, phase 2/3 randomised controlled trial.
Lancet
; 397(10288): 1895-1904, 2021 05 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-33971152
7.
Blood-Based Next-Generation Sequencing in Adrenocortical Carcinoma.
Oncologist
; 27(6): 462-468, 2022 06 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35462410
8.
Immune-Related Adverse Events as Clinical Biomarkers in Patients with Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors.
Oncologist
; 26(10): e1742-e1750, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34156726
9.
Baseline Modified Glasgow Prognostic Score Associated with Survival in Metastatic Urothelial Carcinoma Treated with Immune Checkpoint Inhibitors.
Oncologist
; 26(5): 397-405, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33634507
10.
Body Composition as an Independent Predictive and Prognostic Biomarker in Advanced Urothelial Carcinoma Patients Treated with Immune Checkpoint Inhibitors.
Oncologist
; 26(12): 1017-1025, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34342095
11.
Adiposity may predict survival in patients with advanced stage cancer treated with immunotherapy in phase 1 clinical trials.
Cancer
; 126(3): 575-582, 2020 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31648379
12.
Phase 1 safety and pharmacodynamic study of lenalidomide combined with everolimus in patients with advanced solid malignancies with efficacy signal in adenoid cystic carcinoma.
Br J Cancer
; 123(8): 1228-1234, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32704173
13.
Novel Risk Scoring System for Patients with Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors.
Oncologist
; 25(3): e484-e491, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32162798
14.
Combined Effect of Sarcopenia and Systemic Inflammation on Survival in Patients with Advanced Stage Cancer Treated with Immunotherapy.
Oncologist
; 25(3): e528-e535, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32162807
15.
The prognostic and predictive impact of inflammatory biomarkers in patients who have advanced-stage cancer treated with immunotherapy.
Cancer
; 125(1): 127-134, 2019 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30329148
16.
Clinical outcomes of advanced stage cancer patients treated with sequential immunotherapy in phase 1 clinical trials.
Invest New Drugs
; 37(6): 1198-1206, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30725388
17.
Sites of metastasis and association with clinical outcome in advanced stage cancer patients treated with immunotherapy.
BMC Cancer
; 19(1): 857, 2019 Aug 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-31464611
18.
Race-, Age-, and Gender-Based Characteristics and Toxicities of Targeted Therapies on Phase I Trials.
Oncology
; 95(3): 138-146, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29913438
19.
Time-dependent effects of prognostic biomarkers of systemic inflammation in patients with metastatic renal cell carcinoma.
Tumour Biol
; 39(6): 1010428317705514, 2017 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-28618965
20.
Sarcomatoid urothelial carcinoma of the bladder: a contemporary clinicopathologic analysis of 37 cases.
Can J Urol
; 22(3): 7783-7, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-26068625